EUCTR2009-009517-18-DE进行中（未招募）不适用
A Phase IIa, Multicenter, Randomized, Placebo- and Active-Comparator Controlled,Cross-Over Clinical Trial to Study the Safety and Efficacy of MK-3577 in Patients withType 2 Diabetes Mellitus Who Have Inadequate Glycemic Control - A Study of the Safety and Efficacy of MK-3577 in Patients with Type 2 Diabetes Mellitus.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 333
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •T2DM patients aged 18-70 years who are either drug naïve (AIC range of 6.5-9.5%) or on oral AHA monotherapy or low-dose combination therapy (AIC range of 6.0-9.0%)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •No treatment with PPAR-? agonists (TZDs) or statins within 12 weeks
研究者
相似试验
Unknown
2 期
A Phase IIa, Multicenter, Randomized, Placebo- and Active-Comparator Controlled, Cross-Over Clinical Trial to Study the Safety and Efficacy of MK-3577 in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic ControlCTRI/2009/091/000614Merck Co Inc276
进行中（未招募）
1 期
A Phase IIa, Multicenter, Randomized, Placebo- and Active-Comparator Controlled, Cross-Over Clinical Trial to Study the Safety and Efficacy of MK-3577 in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control - A Study of the Safety and Efficacy of MK-3577 in Patients with Type 2 Diabetes Mellitus.MedDRA version: 9.1 Level: LLT Classification code 10012601 Term: Diabetes mellitusType 2 Diabetes MellitusEUCTR2009-009517-18-GRMerck & co.Inc333
已完成
不适用
A Phase IIa, Multicenter, Randomized, Placebo- and Active-Comparator Controlled, Cross-Over Clinical Trial to Study the Safety and Efficacy of MK-3577 in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic ControlPER-019-09MERCK SHARP & DOHME PERU S.R.L.,
进行中（未招募）
不适用
A Phase IIa, Multicenter, Randomized, Placebo- and Active-Comparator Controlled, Cross-Over Clinical Trial to Study theSafety and Efficacy of MK-3577 in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control - NDEUCTR2009-009517-18-ITMERCK & CO., INC.335
进行中（未招募）
不适用
A Phase IIa, Multicenter, Randomized, Placebo- and Active-Comparator Controlled,Cross-Over Clinical Trial to Study the Safety and Efficacy of MK-3577 in Patients withType 2 Diabetes Mellitus Who Have Inadequate Glycemic Control - A Study of the Safety and Efficacy of MK-3577 in Patients with Type 2 Diabetes Mellitus.Type 2 Diabetes MellitusEUCTR2009-009517-18-HUMerck and Co. Inc.241